Fig. 7

Identification of potential therapeutic agents for high IGS score sub-group. A, A Venn diagram for summarizing included compounds from CTRP and PRISM datasets. B, Schematic outlining the strategy to identify agents with higher drug sensitivity for patients with high-IGS risk score. C, Spearman’s correlation analysis and differential drug response analysis of 2 CTRP-derived compounds. D, Spearman’s correlation analysis and differential drug response analysis of 6 PRISM-derived compounds. E, Identification of most promising therapeutic agents for patients with high IGS-risk score according to the evidence from multiple sources